Standout Papers

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults 2024 202632
  1. Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults (2024)
    Christine A. Shaw, Brandon Essink et al. The Journal of Infectious Diseases

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Achieving Clearance of Drug‐Resistant Bacterial Infection and Rapid Cutaneous Wound Regeneration Using an ROS‐Balancing‐Engineered Heterojunction
2024 Standout
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
2 intermediate papers

Works of Sonia Stoszek being referenced

234. Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV Vaccine in Younger and Older Adult Cohorts: Results from a Phase 1, Randomized Clinical Trial
2022
Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
2010

Author Peers

Author Last Decade Papers Cites
Sonia Stoszek 795 381 569 37 1.2k
Susan J. Skidmore 809 579 1117 53 1.6k
Vytautas Usonis 770 549 281 59 1.3k
Neil Bodsworth 937 384 537 40 1.4k
Ines Ushiro‐Lumb 550 675 764 31 1.5k
E. Claire Newbern 557 261 191 37 1.0k
L. Salleras 741 221 196 69 1.1k
B Christenson 1083 454 193 70 1.6k
Mojca Matičič 742 472 567 74 1.3k
P Lundbergh 715 158 175 55 1.1k
M. Kane 732 427 738 33 1.3k

All Works

Loading papers...

Rankless by CCL
2026